Login / Signup

Ibudilast for prevention of oxaliplatin-induced acute neurotoxicity: a pilot study assessing preliminary efficacy, tolerability and pharmacokinetic interactions in patients with metastatic gastrointestinal cancer.

Christina TengStephanie E ReuterPrunella L BlinmanHaryana M DhillonPeter GalettisNicholas ProschogoAndrew J McLachlanJanette L Vardy
Published in: Cancer chemotherapy and pharmacology (2020)
Trial registration number: UTN U1111-1209-0075 and ANZCTRN12618000232235 (registered 13/02/2018).
Keyphrases
  • papillary thyroid
  • open label
  • phase iii
  • study protocol
  • clinical trial
  • squamous cell
  • phase ii
  • double blind
  • squamous cell carcinoma
  • placebo controlled